Of note is also that the current G-CSF/AMD3100 mobilization regimen triggers leukocytosis and release of pro-inflammatory cytokines from granulocytes, which would be particularly critical in SCD patients.62 The gene discussed is CSF3; the disease is Schnyder corneal dystrophy.